# Lentivirus Transduced Acute Myeloid Leukaemia Blasts Expressing B7.1 (CD80) and IL-2

> **NCT00718250** · PHASE1 · UNKNOWN · sponsor: **King's College Hospital NHS Trust** · enrollment: 24 (estimated)

## Conditions studied

- Leukemia, Myeloid, Acute

## Interventions

- **BIOLOGICAL:** RFUSIN2-AML1
- **BIOLOGICAL:** Donor leukocyte infusion (DLI)
- **BIOLOGICAL:** RFUSIN2-AML1 and donor leukocyte infusion
- **BIOLOGICAL:** RFUSIN2-AML1 and donor leukocyte infusion

## Key facts

- **NCT ID:** NCT00718250
- **Lead sponsor:** King's College Hospital NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-05
- **Primary completion:** 2011-05
- **Final completion:** 2012-02
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2008-07-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00718250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00718250, "Lentivirus Transduced Acute Myeloid Leukaemia Blasts Expressing B7.1 (CD80) and IL-2". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00718250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*